Selective estrogen receptor modulators: clinical spectrum.
Selective estrogen receptor modulators: clinical spectrum.
复制标题
DOI：
10.1210/edrv.20.3.0371
复制
发表时间：
1999-06
影响因子：
20.3
通讯作者：
F. Cosman;R. Lindsay
中科院分区：
文献类型：
--
作者：
F. Cosman;R. Lindsay
I.二、导言乳腺影响A.原发性乳腺癌无转移的女性B。患有转移性疾病的女性C.乳腺癌的预防生殖系统影响A.子房B。子宫角阴道D神经内分泌IV.骨骼效应：骨量、骨代谢和骨折发生率。他莫昔芬B。雷洛昔芬对血管系统的影响：中间标记物和疾病结局。中间标记B。血管疾病结局VI.中枢神经系统影响A.认知功能和情绪B。七、眼疾肝脏效应VIII.九、其他影响结论
I. Introduction II. Breast Effects A. Women with primary breast cancer without metastases B. Women with metastatic disease C. Breast cancer prevention III. Reproductive System Effects A. Ovary B. Uterus C. Vagina D. Neuroendocrine IV. Skeletal Effects: Bone Mass, Bone Metabolism, and Fracture Occurrence A. Tamoxifen B. Raloxifene V. Vascular System Effects: Intermediate Markers and Disease Outcomes A. Intermediate markers B. Vascular disease outcomes VI. Central Nervous System Effects A. Cognitive function and mood B. Eye disease VII. Hepatic Effects VIII. Miscellaneous Effects IX. Conclusion